Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome
P Strati, H Kantarjian, F Ravandi… - American journal of …, 2015 - Wiley Online Library
We investigated the combination of midostaurin and azacitidine (AZA) in patients with acute
myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS). Patients received …
myeloid leukemia (AML) and high risk myelodysplastic syndrome (MDS). Patients received …